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Background:  _v`3-fumagillin nanoparticles (NP) decrease angiogenesis in atherosclerotic rabbit models, but drug losses from NPs in circulation 
and chemical instability of fumagillin complicate translation. To develop a prodrug (PD) platform for improved chemical and circulatory stability of 
drugs in lipid-based NPs.
Methods:  PD of fumagillin was coupled to the Sn-2 acyl position of phosphatidylcholine, which included removal of fumagillin light sensitivity. PD 
were formulated in perfluorocarbon NPs and studied in 2F2B endothelial cell proliferation assays. Efficacy of _v`3-fumagillin-PD NP, nontargeted-
fumagillin-PD NP, _v`3-fumagillin NP and _v`3-no drug NP were studied in a Matrigel mouse angiogenesis model. Mice (N=6/grp) were treated on 
days 6, 9, and 12 post-implantation and neovascularity imaged on day 16 with MRI and _v`3-paramagnetic NP.
Results:  _v`3-PD NPs decreased (p<0.05) cell proliferation equal or better than equi-molar doses of free drug. _v`3-fumagillin-PD NP 
decreased (p<0.05) Matrigel angiogenesis; no effects were measured in the other groups.
Conclusions:  Sn-2 fumagillin PD offer improved chemical and circulatory stability in lipid-based NPs, facilitating translation of NP-based 
antiangiogenic treatment for atherosclerosis. 
